Clinical Trial Update: Dietary Fish Protein in Subjects With Insulin Resistance [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dietary fish protein in people with insulin resistance and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dietary fish protein

Snippet

Sponsor: Laval University | Conditions: Insulin Resistance, Type 2 Diabetes | Phase 2 | Status: COMPLETED